US Patent Issued to TENEOBIO on March 31 for "Agonistic anti-IL-2R antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,163, issued on March 31, was assigned to TENEOBIO INC. (Thousand Oaks, Calif.).

"Agonistic anti-IL-2R antibodies and methods of use" was invented by Nathan Trinklein (Redwood City, Calif.), Katherine Harris (Fremont, Calif.), Kyle Lorentsen (Dublin, Calif.), Harbani Kaur Malik Chaudhry (Oakland, Calif.) and Kaitlyn Loughlin (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-IL2R (e.g., anti-IL2RB, anti-IL2RG, anti-IL2RB/G) antibodies are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and use of such antibodies and compositions in the treat...